2. Gene
  3. Mpg - N-methylpurine-DNA glycosylase Gene

Mpg - N-methylpurine-DNA glycosylase Gene

  • Gene
  • Protein
  • Agent
  • Ortholog
Mus musculus

Also known as Aag; APNG; Mid1; 9830006D05

Gene ID: 268395 | Gene type: protein coding

About Mpg

Summary

Enables alkylbase DNA N-glycosylase activity. Acts upstream of or within base-excision repair. Predicted to be located in cytosol and nucleoplasm. Is expressed in several structures, including early conceptus; gonad; hemolymphoid system gland; musculature; and placenta. Orthologous to human MPG (N-methylpurine DNA glycosylase). [provided by Alliance of Genome Resources, Apr 2022]

Mpg Products(1)

mRNA Protein Name
NM_010822.3 NP_034952.2 DNA-3-methyladenine glycosylase
Gene Ontology
  • Molecular Function
  • Biological Process
Molecular Function GO Annotation Evidence Reference Source
enables alkylbase DNA N-glycosylase activity IDA
IDA: Inferred from direct assay
8435858 MGI
enables alkylbase DNA N-glycosylase activity IMP
IMP: Inferred from mutant phenotype
9371767 MGI
Biological Process GO Annotation Evidence Reference Source
acts upstream of or within base-excision repair IMP
IMP: Inferred from mutant phenotype
9371767 MGI
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

DNA-3-methyladenine glycosylase

3-alkyladenine DNA glycosylase

3-methyladenine DNA glycosidase

3-methyladenine DNA glycosylase

ADPG

alkylpurine-DNA-N-glycosylase

Related Agents

Approval
Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-B0084 Dienogest Agonist 99.93% Unkown
Clinical Phase
Bioactive Molecules (3)
Cat. No. Product Name Effect
Purity Phase
HY-139364 mPGES1-IN-4 Inhibitor / Phase 4
HY-147416 Vipoglanstat Inhibitor 99.81% Phase 2
HY-139589 Zaloglanstat 98.50% Phase 1
Pre-clinical Phase
Bioactive Molecules (42)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-118119 CAY10526 Inhibitor 99.12% Unkown
HY-Y0958 Methoxyamine hydrochloride ≥98.0% Unkown
HY-13283 MF63 Inhibitor 99.55% Unkown
HY-108259 HQL-79 Inhibitor 99.89% Unkown
HY-100800 TACA Agonist 99.33% Unkown
HY-149202 UT-11 Inhibitor 99.62% Unkown
HY-W749694 Cannflavin B Inhibitor 98.36% Unkown
HY-P4076 MPG peptides, Pβ 98.48% Unkown
HY-10439 HPGDS inhibitor 1 Inhibitor 99.42% Unkown
HY-125415 PF-4693627 Inhibitor 99.63% Unkown
HY-111140 YS121 99.74% Unkown
HY-118282 mPGES1-IN-7 Inhibitor 99.78% Unkown
HY-162387 UK4b Inhibitor 96.17% Unkown
HY-125975 1-Naphthyl 3,5-dinitrobenzoate Inhibitor 99.49% Unkown
HY-19622 PF-9184 Inhibitor 98.10% Unkown
HY-100864 mPGES1-IN-3 Inhibitor / Unkown
HY-117008 CAY10589 Inhibitor / Unkown
HY-126898 5-LO/mPGES1-IN-1 Inhibitor 99.00% Unkown
HY-139365 mPGES1-IN-5 Inhibitor / Unkown
HY-144237 BRP-201 / Unkown
HY-144238 mPGES1-IN-6 / Unkown
HY-156612 Friluglanstat Inhibitor / Unkown
HY-162166 COX-2/15-LOX/mPGES1-IN-1 Inhibitor / Unkown
HY-163736 mPGES-1/5-LOX-IN-1 Inhibitor / Unkown
HY-169430 AGU654 Inhibitor / Unkown
HY-170610 mPGES-1/sEH-IN-1 Inhibitor / Unkown
HY-171237 mPGES1-IN-9 Inhibitor / Unkown
HY-172713 DSPE-PEG1000-MPG / Unkown
HY-172714 DSPE-PEG2000-MPG / Unkown
HY-172714A DSPE-PEG3400-MPG / Unkown
HY-172715 DSPE-PEG5000-MPG / Unkown
HY-B0084S4 Dienogest-13C,15N,d4 Agonist / Unkown
HY-N9814 Shanciol B Inhibitor / Unkown
HY-P1566 MPG, HIV related / Unkown
HY-RS08611 MPG Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-118184 AF3485 Inhibitor / Unkown
HY-122064 FR20 Inhibitor / Unkown
HY-13475 mPGES1-IN-8 Inhibitor / Unkown
HY-164358 α-Gracinoic acid Inhibitor / Unkown
HY-169858 Prostaglandin E2 Inhibitor 3 Inhibitor / Unkown
HY-RS18738 Mpg Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS25225 Mpg Rat Pre-designed siRNA Set A Pre-designed Set / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Mpg NCBI NCBI:4350